Showing 1–20 of 78 results
Acne Leukopak
LeukoCore™ Acne Leukopak products contain concentrated immune cells from donors with clinically confirmed acne, collected via apheresis. Ideal for high-yield studies on acne-related inflammation, cytokine signaling, and immune cell profiling.
Allergy Leukopak
LeukoCore™ Allergy Leukopak products contain concentrated immune cells from donors with clinically confirmed allergies, collected via apheresis. Ideal for high-yield studies on allergy-related inflammation, cytokine signaling, and immune cell profiling.
Alopecia Leukopak
LeukoCore™ Alopecia Leukopak products contain concentrated immune cells from donors with clinically confirmed alopecia, collected via apheresis. Ideal for high-yield studies on autoimmune hair loss, T cell–mediated follicular damage, and immune profiling in dermatological research.
Alpha-Gal Syndrome Leukopak
LeukoCore™ Alpha-Gal Syndrome Leukopak products contain concentrated immune cells from donors with clinically confirmed alpha-gal syndrome (AGS), collected via apheresis. Ideal for high-yield studies on AGS-related inflammation, cytokine signaling, and immune cell profiling.
Ankylosing Spondylitis Leukopak
LeukoCore™ Ankylosing Spondylitis Leukopak products contain concentrated immune cells from donors with clinically confirmed ankylosing spondylitis, collected via apheresis. Ideal for high-yield studies on axial inflammation, HLA-B27-associated immune responses, and T cell–mediated pathogenesis in spondyloarthropathies.
Arrhythmia Leukopak
LeukoCore™ Arrhythmia Leukopak products contain concentrated immune cells from donors with clinically confirmed Arrhythmia, collected via apheresis. Ideal for high-yield studies on arrhythmia-associated inflammation, cardiac immune mechanisms, and immune cell profiling.
Arthritis Leukopak
LeukoCore™ Arthritis Leukopak products contain concentrated immune cells from donors with clinically confirmed arthritis, collected via apheresis. Ideal for high-yield studies on arthritis-related inflammation, cytokine signaling, and immune cell profiling.
Asthma Leukopak
LeukoCore™ Asthma Leukopak products contain concentrated immune cells from donors with clinically confirmed asthma, collected via apheresis. Ideal for high-yield studies on asthma-related inflammation, cytokine signaling, and immune cell profiling.
Atherosclerosis Leukopak
LeukoCore™ Atherosclerosis Leukopak products contain concentrated immune cells from donors with clinically confirmed atherosclerosis, collected via apheresis. Ideal for high-yield studies on vascular inflammation, immune-driven plaque development, and monocyte and T cell involvement in cardiovascular disease.
Atopic Dermatitis Leukopak
LeukoCore™ Atopic Dermatitis Leukopak products contain concentrated immune cells from donors with clinically confirmed atopic dermatitis, collected via apheresis. Ideal for high-yield studies on atopic dermatitis-related inflammation, cytokine signaling, and immune cell profiling.
Breast Cancer Leukopak
LeukoCore™ Breast Cancer Leukopak products contain concentrated immune cells from donors with clinically confirmed breast cancer, collected via apheresis. Ideal for high-yield studies on breast cancer-related studies examining genetic risk factors and develop new therapeutic approaches.
Celiac Disease Leukopak
LeukoCore™ Celiac Disease Leukopak products contain concentrated immune cells from donors with clinically confirmed celiac disease, collected via apheresis. Ideal for high-yield studies on celiac disease-related immune response and disease mechanisms.
Chronic Kidney Disease Leukopak
LeukoCore™ Chronic Kidney Disease Leukopak products contain concentrated immune cells from donors with clinically confirmed chronic kidney disease (CKD), collected via apheresis. Ideal for high-yield studies on the role of leukocytes in the development and progression of CKD and related inflammatory conditions
CIDP Leukopak
LeukoCore™ CIPD Leukopak products contain concentrated immune cells from donors with clinically confirmed chronic inflammatory demyelinating polyneuropathy (CIDP), collected via apheresis. Ideal for high-yield studies on peripheral nerve autoimmunity, demyelination mechanisms, and immune cell profiling.
Cirrhosis Leukopak
LeukoCore™ Cirrhosis Leukopak products contain concentrated immune cells from donors with clinically confirmed cirrhosis, collected via apheresis. Ideal for high-yield studies on liver inflammation, immune-mediated fibrogenesis, and immune profiling in chronic liver disease.
Colorectal Cancer Leukopak
LeukoCore™ Colorectal Cancer Leukopak products contain concentrated immune cells from donors with clinically confirmed colorectal cancer, collected via apheresis. Ideal for high-yield studies on tumor-immune interactions, T cell responses, and immune biomarkers in gastrointestinal oncology research.
COPD Leukopak
LeukoCore™ COPD Leukopak products contain concentrated immune cells from donors with clinically confirmed chronic obstructive pulmonary disease (COPD), collected via apheresis. Ideal for high-yield studies on COPD disease development and progression.
Coronary Artery Disease Leukopak
LeukoCore™ Coronary Artery Disease Leukopak products contain concentrated immune cells from donors with clinically confirmed coronary artery disease, collected via apheresis. Ideal for high-yield studies on vascular inflammation, immune contributions to atherosclerotic plaque development, and cardiovascular immunology.
Covid-19 Leukopak
LeukoCore™ Covid-19 Leukopak products contain concentrated immune cells from donors with clinically confirmed Covid-19 donors, collected via apheresis. Ideal for high-yield studies on Covid-19-related inflammation, cytokine signaling, and immune cell profiling.